Summary
Concentration gradients in lumbar cerebrospinal fluid (CSF) for the monoamine metabolites homovanillic acid (HVA), 5-hydroxy-indoleacetic acid (5-HIAA) and 4-hydroxy-3-methoxyphenylglycol (HMPG) were studied in 9 healthy controls and 47 neuropsychiatric patients without diseases causing disturbed CSF circulation. In a serial sampling of the first 24 ml of CSF, steep concentration gradients between the first (0–4 th ml) and last (21th–24th ml) portions of CSF were found for HVA (99±59% increase; p<0.001) and 5-HIAA (88±54% increase; p<0.001), while the concentration gradient was slight for HMPG (11±7% increase; p<0.001). The existence of marked concentration gradients for the monoamine metabolites HVA and 5-HIAA gives further evidence for an active transport system for these metabolites and indicates that the lumbar CSF-HVA and 5-HIAA levels reflect the dopamine and serotonin metabolism in the brain. Moreover, the existence of pronounced concentration gradients for HVA and 5-HIAA levels reflect the dopamine and serotonin metabolism in the brain. Moreover, the existence of pronounced concentration gradients for HVA and 5-HIAA stresses the importance of making analyses on a standardized volume of CSF.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adèr JP, Aizenstein ML, Postema F, Korf J (1979) Origin of free 3-methoxy-4-hydroxyphenylethyleneglycol in rat cerebrospinal fluid. J Neural Transm 46: 279–290
Andersen O, Johansson B, Svennerholm L (1981) Monoamine metabolites in successive samples of spinal fluid. Acta Neurol Scand 63: 247–254
Aschcroft GW, Dow RC, Moir ATB (1968) The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog. J Physiol 199: 397–425
Bartholini G, Pletscher A, Tissot R (1966) On the origin of homovanillic acid in the cerebrospinal fluid. Experientia 22: 609–610
Bertilsson L, Åsberg, M, Lantto O, Scalia-Tomba GP, Träskman-Bendz L, Tybring G (1982) Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls. Psychiatry Res 6: 77–83
Blennow K, Wallin A, Gottfries CG, Karlsson I, Månsson JE, Skoog I, Svennerholm L, Wikkelsö C (1991a) Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18–88 years of age (submitted)
Blennow K, Wallin A, Gottfries CG, Lekman A, Karlsson I, Svennerholm L (1991b) Significance of reduced lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease et al. Neurobiol Aging 13: 107–113
Blennow K, Rybo E, Wallin A, Gottfries CG, Svennerholm L (1991c) Cerebrospinal fluid cytology in Alzheimer's disease. Dementia 2: 25–29
Blennow K, Fredman P, Wallin A, Gottfries CG, Långström G, Svennerholm L (1992) Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on CSF/S albumin ratio. Eur Neurol (in press)
Cutler N, Kay A, Ågren H, Linnoila M, Potter W (1988) Cerebrospinal fluid monoamine metabolites levels in 32 healthy men aged 19–77 years. Brain Dysfunct 1: 192–196
Degrell I, Nagy E (1990) Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid. Biol Psychiatry 27: 891–896
DiChiro G (1964) Movement of the cerebrospinal fluid in human beings Nature 204: 290–291
Ebert M, Kartzinel R, Cowdry R, Goodwin F (1980) Cerebrospinal fluid amine metabolites and the probenicide test. In: Wood JH (ed) Neurobiology of cerebrospinal fluid. Plenum Press, New York, pp 97–112
Eccleston D, Ashcroft GW, Moir ATB, Parker-Rhodes A, Lutz W, O'Mahoney DP (1968) A comparison of 5-hydroxyindoles in various regions of dog brain and cerebrospinal fluid. J Neurochem 15: 947–957
Garelis E, Sourkes TL (1973) Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry 36: 625–629
Gateless D, Stanley M, Träskman-Bendz L, Gilroy J (1984) The influence of the lying and sitting positions on the gradients of 5-HIAA and HVA in lumbar cerebrospinal fluid. Biol Psychiatry 19: 1585–1589
Gjerris A, Werdelin L, Gjerris F, Sörensen PS, Rafaelsen OJ, Alling C (1987) CSF-amine metabolites in depression, dementia and in controls. Acta Psychiatr Scand 75: 619–628
Gordon E, Perlow M, Oliver J, Ebert M, Kopin I (1975) Origins of catecholamine metabolites in monkey cerebrospinal fluid. J Neurochem 25: 347–349
Gottfries CG, Gottfries I, Johansson V, et al (1971) Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Neuropharmacology 10: 665–672
Jakupcevic M, Lackovic Z, Stefoski D, Bulat M (1977) Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebrospinal fluid of man. J Neurol Sci 31: 165–171
Johansson B, Roos BE (1975) Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid. Acta Neurol Scand 52: 137–144
Kopin IJ, Gordon EK, Jimerson DC, Polinsky RJ (1983) Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science 219: 73–75
Post RM, Goodwin EK, Gordon E (1973) Amine metabolism in human cerebro spinal fluid: effects of cord transection and spinal fluid block. Science 179: 879–899
Scheinin M (1985) Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Med Biol 63: 1–17
Siever L, Kraemer H, Sack R, Angwin P, Berger P, Zarcone V, Barchas J, Brodie KH (1975) Gradients of biogenic amine metabolites in cerebrospinal fluid. Dis Nerv Syst 36: 13–16
Sjöquist B, Lindström B, Änggård E (1975) Mass fragmentographic determination of 4-hydroxy-3-methoxyphenylglycol (HMPG) in urine, cerebrospinal fluid, plasma and tissue using a deuterium-labelled internal standard. J Chromatogr, 105: 309–316
Sjöström R, Ekstedt J, Änggård E (1975) Concentration gradients of monoamine metabolites in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry 38: 666–668
Sourkes TL (1973) On the origin of homovanillic acid (HVA) in the cerebrospinal fluid. J Neural Transm 34: 153–157
Stanley M, Träskman-Bendz L, Dorovini K (1985) Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 37: 1279–1286
Swahn C-G, Sandgärde B, Wiesel F-A, Sedvall G (1976) Simultaneous deter-mination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method. Psychopharmacology 48: 147–152
Van der Poel FW, van Praag HM, Korf J (1977) Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space. Psychopharmacology 52: 35–40
Weir RL, Chase TN, Ng LKY, Kopin IJ (1973) 5-hydroxyindoleacetic acid in spinal fluid: relative contribution from brain and spinal cord. Brain Res 52: 409–412
Wode-Helgodt B, Sedvall G (1978) Correlations between height of subject and concentrations of monoamine metabolites in the cerebrospinal fluid from psychotic men and women. Commun Psychopharmacol 2: 177–183
Wood JH (1980) Sites of origin and cerebrospinal fluid concentration gradients: neurotransmitters, their precursors and metabolites, and cyclic nucleotides. In: Wood JH (ed) Neurobiology of cerebrospinal fluid. Plenum Press, New York, pp 53–62
Ziegler MG, Wood JH, Lake CR, Kopin IJ (1977) Norepinephrine and 3-methoxy-4-hydroxyphenyl glycol gradients in human cerebrospinal fluid. Am J Psychiatry 134: 565–568
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blennow, K., Wallin, A., Gottfries, C.G. et al. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. J Neural Transm Gen Sect 5, 5–15 (1993). https://doi.org/10.1007/BF02260910
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02260910